FDA Warns SNOO Bassinet Maker Over Violations And Sanitary Issues
On June 16, 2026, the U.S. Food and Drug Administration issued a warning letter to Happiest Baby Inc., maker of the SNOO bassinet, over alleged violations and unsanitary conditions.[1]
The FDA said the company sold some unauthorized SNOO-related products and flagged unsanitary conditions that could prompt enforcement if the issues are not corrected.[1]
An FDA inspection of Happiest Baby's Los Angeles facility from July 21 through July 25, 2025, found the company had added X-Small and X-Large sleep sack sizes and a hospital bundle without authorization. Inspectors also cited quality-system failures, including poor handling of complaints about mold on mattresses and unsanitary practices with refurbished units.
Healthcare and pediatric accounts amplified the FDA MedWatch alert online, and business coverage highlighted the SNOO's roughly $1,700 price as the scrutiny drew attention to a premium consumer product facing potential regulatory action.
The mainstream summary does not mention the broader context of the FDA's regulatory environment, which has seen a notable increase in enforcement actions. In 2025 alone, the FDA issued 54 warning letters related to medical devices, accounting for about 8% of all warning letters issued that year, indicating a heightened scrutiny that could be relevant to understanding the implications of the SNOO bassinet's violations.[2]
Additionally, the summary overlooks the direct implications of these violations for clinical practice, as highlighted by healthcare professionals on social media. The FDA's warning letter cites multiple violations that could affect pediatric care, emphasizing the potential risks associated with the SNOO bassinet's unsanitary conditions and unauthorized products. This perspective underscores the importance of regulatory compliance in ensuring the safety of medical devices for infants, a detail that could resonate strongly with concerned parents and healthcare providers alike.
Show source details & analysis (1 source)
📊 Relevant Data
The FDA issued 54 warning letters related to medical devices in 2025, representing about 8% of the agency's total 695 warning letters that year.
US FDA CDRH Warning Letters: A Review of 2025 — Emergo by UL
📌 Key Facts
- On June 16, 2026, CBS reported that FDA issued a warning letter to Happiest Baby Inc., maker of the SNOO bassinet.
- The FDA letter alleges the company sold some unauthorized products tied to the SNOO line.
- The FDA also cited unsanitary conditions at the company, signaling possible follow-up enforcement if violations are not corrected.
📰 Source Timeline (1)
Follow how coverage of this story developed over time